Skip to content

Opko Health OPK Free cash flow margin

Free cash flow margin at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
11.8%+1.4pp
HRO
HarrowHROW
5.7%+5.0pp
Precigen logo
PrecigenPGEN
-1,756.5%
Immunome logo
ImmunomeIMNM
-5,118.9%-8,601pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-75.1%+10.7pp
Abbott logo
AbbottABT
16.3%+0.6pp

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on trailing twelve months.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's free cash flow margin?
Opko Health (OPK) reported free cash flow margin of -30% in Q1 2026.
How has Opko Health's free cash flow margin changed year-over-year?
Opko Health's free cash flow margin decreased by 0.2% year-over-year, from -29.9% to -30%.
What is the long-term trend for Opko Health's free cash flow margin?
Over 3 years (2020 to 2025), Opko Health's free cash flow margin has grown at a 327.1% compound annual growth rate (CAGR), from 0.4% to -31.4%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.